Carlos E. Galera
Murcia, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Impact of HIV infection on the dynamics of liver stiffness in patients with hepatitis C virus chronic infection after sustained virological response.
Journal: EClinicalMedicine
Published: October 10, 2024
No Impact of HIV Coinfection on Mortality in Patients With Hepatitis C Virus Infection After Sustained Virological Response.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 14, 2024
Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 01, 2024
Correction: Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
Journal: Trials
Published: September 27, 2023
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study.
Journal: The Journal of antimicrobial chemotherapy
Published: September 15, 2023
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
Journal: Frontiers in immunology
Published: July 12, 2023
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice.
Journal: The Journal of antimicrobial chemotherapy
Published: May 17, 2023
Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain.
Journal: AIDS research and human retroviruses
Published: March 31, 2022
Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens.
Journal: Frontiers in immunology
Published: January 04, 2022
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 15, 2021
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Journal: Medicine
Published: November 12, 2021
A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure.
Journal: Diagnostics (Basel, Switzerland)
Published: July 14, 2021
Last Updated: 09/26/2026